(Q40026514)
Statements
Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells (English)
Clara Lemos
Christina Tekle
Kees Smid
Simona Ricciardi
Godefridus J Peters
10 January 2008